Literature DB >> 14522018

Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPbeta to the promoter.

Alok Agrawal1, David Samols, Irving Kushner.   

Abstract

Induction of C-reactive protein (CRP) synthesis in hepatocytes by cytokines occurs at the transcriptional level. In Hep3B cells, the transcription factors C/EBPbeta, STAT3, and Rel p50 have been shown to participate in this process. A C/EBP binding site centered at -53 and an overlapping nonconsensus kappaB site on the promoter are critical for CRP expression. We have previously found that an oligonucleotide containing a kappaB site diminished binding of C/EBPbeta to the C/EBP site, suggesting that unidentified Rel proteins present in Hep3B nuclei facilitate the formation of C/EBPbeta-complexes. The current studies were undertaken to determine which of the five Rel proteins, p50/p65/p52/c-Rel/RelB, play such a role. Mutation of the nonconsensus kappaB site did not abolish binding of C/EBPbeta to its binding site, indicating that this site was not necessary for the formation of C/EBPbeta-complexes. Depletion of Rel proteins from Hep3B nuclei led to decreased formation of C/EBPbeta-complexes on a CRP promoter-derived oligonucleotide that contained only the intact C/EBP binding site but not the nonconsensus kappaB site. This finding indicates that Rel proteins are involved in the binding of C/EBPbeta to its binding site by a kappaB site-independent mechanism. Electrophoretic mobility shift assays (EMSAs) revealed that it was c-Rel that facilitated formation of C/EBPbeta-complexes and that c-Rel bound directly to C/EBPbeta-complexes formed on the C/EBP site. Cotransfection of c-Rel enhanced the induction of CRP promoter-driven luciferase activity and enhanced endogenous CRP expression in cells transfected with C/EBPbeta. We conclude that c-Rel regulates CRP expression without the requirement of binding to a kappaB site, and binds directly to C/EBPbeta to facilitate the binding of C/EBPbeta to the CRP promoter.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522018     DOI: 10.1016/s0161-5890(03)00148-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  19 in total

1.  Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoter.

Authors:  Bhavya Voleti; Alok Agrawal
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  Exposure to coplanar PCBs induces endothelial cell inflammation through epigenetic regulation of NF-κB subunit p65.

Authors:  Dandan Liu; Jordan T Perkins; Michael C Petriello; Bernhard Hennig
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-28       Impact factor: 4.219

3.  Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta.

Authors:  Joachim R Karlsen; Niels Borregaard; Jack B Cowland
Journal:  J Biol Chem       Date:  2010-03-10       Impact factor: 5.157

4.  Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist.

Authors:  Bhavya Voleti; Alok Agrawal
Journal:  Mol Immunol       Date:  2005-07-28       Impact factor: 4.407

5.  Effect of wine phenolics on cytokine-induced C-reactive protein expression.

Authors:  G Kaur; L V M Rao; A Agrawal; U R Pendurthi
Journal:  J Thromb Haemost       Date:  2007-06       Impact factor: 5.824

6.  Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.

Authors:  Jacqueline T Brown; Yuan Liu; Julie M Shabto; Dylan J Martini; Deepak Ravindranathan; Emilie Elise Hitron; Greta Anne Russler; Sarah Caulfield; Lauren Beth Yantorni; Shreyas S Joshi; Haydn Kissick; Kenneth Ogan; Wayne B Harris; Bradley C Carthon; Omer Kucuk; Viraj A Master; Mehmet Asim Bilen
Journal:  Oncologist       Date:  2021-03-18

7.  Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation.

Authors:  Alexander P Reiner; Mark M Wurfel; Leslie A Lange; Christopher S Carlson; Alex S Nord; Cara L Carty; Mark J Rieder; Cindy Desmarais; Nancy S Jenny; Carlos Iribarren; Jeremy D Walston; O Dale Williams; Deborah A Nickerson; Gail P Jarvik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

8.  Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein.

Authors:  Alexander P Reiner; Mathew J Barber; Yongtao Guan; Paul M Ridker; Leslie A Lange; Daniel I Chasman; Jeremy D Walston; Gregory M Cooper; Nancy S Jenny; Mark J Rieder; J Peter Durda; Joshua D Smith; John Novembre; Russell P Tracy; Jerome I Rotter; Matthew Stephens; Deborah A Nickerson; Ronald M Krauss
Journal:  Am J Hum Genet       Date:  2008-04-24       Impact factor: 11.025

9.  Effect of obesity on the association between common variations in the PPAR gene and C-reactive protein level in Chinese Han population.

Authors:  Shu-Jun Gu; Dong-Hui Chen; Zhi-Rong Guo; Zheng-Yuan Zhou; Xiao-Shu Hu; Ming Wu
Journal:  Endocrine       Date:  2014-03-07       Impact factor: 3.633

10.  A novel RBP-J kappa-dependent switch from C/EBP beta to C/EBP zeta at the C/EBP binding site on the C-reactive protein promoter.

Authors:  Prem Prakash Singh; Bhavya Voleti; Alok Agrawal
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.